SlideShare ist ein Scribd-Unternehmen logo
1 von 35
Downloaden Sie, um offline zu lesen
Millstone
Packaging Solutions: Increase speed to market and lower costs
Kelly Lucenti, President
Common Problems
Getting your product to
market faster
Common Problems
• Packaging Development
• Understanding different packaging configurations and the benefits, costs and
lead times associated with each
• Selecting an appropriate sterile barrier
• Validating the Design
• Validations
• Determining necessary validations
• Understanding the timeline associated with each validation type
• Costs associated with each validation type
• Re-executing if a validation fails; time and costs associated re-execution
Common Problems
• Inadequate resources
• Capabilities
• Inspection requirements – people and equipment
• Cleaning requirements / equipment
• Assembly & packaging requirements / equipment
• People - not enough operators to support volume and lead time requirements
• Equipment
• Need more pouch or tray sealers
• Need more inspection equipment
• Technology is important for running efficient inspection cells & clean room spaces
• Capacity
• Not enough capacity to support the launch of new product lines
• Not enough space for anticipated volumes
Common Problems
• Staying on top of industry standards
• Quality
• Mixed product
• Inadequate seals
• Lead Times
• Launch deadlines
• Validation lead times
Solutions
Prepare for successful &
timely validations
Preparing for successful & timely validations
Choose the right packaging configuration
• Understand how your device will be used in a clinical setting
• Evaluate the benefits of different packaging options
Tray
Benefits: Compact Design, Space
Preferred for Aseptic Transfer
Costs: More
Lead Times: Molding - 6 weeks
Tray Sealing Fixture - 8 weeks
Pouch
Benefits: Cost Effective, Space
Ability to Fit Multiple Designs
Costs: Less
Lead times: Die - 6 weeks
Figure 1
• Consider the “problem areas” associated with the device
• Sharp edges, weight of implant – anything that could cause a failed validation
• Incorporating tip protectors, mounting cards or tray inserts into your package design to protect
the implant
• What type of sterilization will be required?
• Packaging systems must be designed accordingly
• For example: EtO requires semi-permeable sterile barriers, allowing gas to enter the packaging
without creating a pressure differential that could lead to a burst or leak of the pouch/tray.
Being aware of all details can prevent significant delays during the
validation process
Preparing for successful & timely validations
Determine what validations are required
Validation Documenting Procedures
• Installation Qualification (IQ): Objective Evidence that the manufacturing equipment is
installed and connected to the appropriate utilities in accordance with its approved design
criteria and the manufacturer’s specifications.
• Operational Qualification (OQ): Objective Evidence that the process equipment and ancillary
systems, as defined in the Installation Qualification are capable of consistently operating within
established limits and tolerances.
• Process Qualification (PQ): Objective evidence that the process is effective and reproducible and
that the outcome produced meets all requirements for safety and efficacy.
ISO requires a methodical, documented process to detail the purpose, scope and
procedure of each validation followed by a final report to document the results
Validation Types:
Sealer IQ
Ensure sealer is installed
properly
Sealing OQ
Develop sealing
parameters (min, nominal,
max) and test at challenge
conditions
Sealing PQ
Test nominal parameters
for effective, reproducible
results
Distribution Testing PQ
Test interaction between
product & sterile barrier
Aging PQ
Test the effect of aging on
sterile barrier
Sealing Validations
Determine what validations are required
Figure 2
Sealing Validations
• What is an appropriate sample size?
Things to consider: the level of risk severity and
probability associated with the given process. If
a failure results in significant harm or damage,
a larger sample size should be used to validate
the process.
Bayes Success-Run Theorem – a typical method
based on a binomial distribution that leads to a
defined sample size.
Determine what validations are required
Figure 3
Sealing Validations
• What tests should the samples be subjected to?
Things to consider when challenging a sterile barrier:
• Qualitative techniques – seal integrity-visual inspection, bubble leak, dye penetration
• Quantitative techniques – seal strength
Using these test methods, you can develop an acceptance criteria and
begin executing. Understanding this beforehand will allow for a seamless
transition between package design and validation execution.
Determine what validations are required
Distribution Testing & Aging Validations
Validating the interaction between the product
and the sterile barrier
These validations must be performed at worst
case conditions and should be subjected to
qualitative and quantitative test methods.
Determine what validations are required
Consider
Potential
Failure
Modes
DesignTest
Figure 4
Determine what validations are required
Distribution Testing
• Validates that the chosen sterile barrier is maintained during the shipping process
(according to ASTM D4169).
• Involves packaging product into its final packaging configuration (sterile barrier,
unit cartons with IFUs, labels, etc.) and subjecting to a defined conditioning and
distribution cycle.
It is vital to choose a suitable sterile barrier during the design stage to
avoid failure during this validation step and prevent significant delays in
the validation process.
• Company example: Failed ship testing
Determine what validations are required
Aging Validations / Shelf Life Testing
• Validates that the sterile barrier can be maintained through a given period of time which
provides an expiration date for the medical device (ASTM F1980).
• Accelerated Aging manipulates humidity and temperature levels to hasten the testing
process and reach market faster. It is important to note that the ISO standard indicates
that Real Time Aging is required to substantiate this data.
• To avoid potential issues with Accelerated Aging, be sure to check the pouch/tray supplier’s
suggested humidity and temperature levels. Exceeding these can yield negative results due
to the extreme conditions.
• When testing, it is important to choose the part that has the greatest failure potential to the
sterile barrier, thus ensuring that the integrity of the sterile barrier is maintained when the
product reaches market.
Key Takeaways
A failure during these validations can create significant delays in
reaching market; failure in the field leads to a recall, liability, and
harm to the end-user. Re-execution of validations is costly.
Reviewing potential failure modes as well as the intricacies of these
validations will provide a proper transition from the process
validation stage to getting your product to market in a safe,
effective manner.
Preparing for successful and timely validations
Stage 1
MMO Validation Flowchart
MMO Validation Flowchart
Stage 2
Solutions
Pre-validated packaging
configurations
Pre-validated Packaging
One of the quickest, easiest, most cost-effective ways to get your
medical device to market.
• Eliminates tooling & design costs
• Packaging available in both tray and pouch configurations
• Pre-validated to meet industry recognized standards
• Compatible with various methods of sterilization
• Reduces resource needs & costs
• Increases speed to market (see validation timeline)
Solutions
Universal Packaging
Universal Packaging
One of the quickest, easiest, most cost-effective ways to get more
of your products to market
• Single packaging configuration that accommodates hundreds
to thousands of various sized implants
• Reduces validation costs and protocol development
• Allows packaging across multiple product lines
• Reduces “footprint” of packaging companies
Universal Packaging
Universal Packaging Option (Barger Packaging & Millstone)
• Millstone teamed up with Barger and developed a special packaging that fits
roughly 80% of spinal and extremity implants
• Double-sterile barrier thermoform tray with two polyurethane liners for
protection, inner and outer Tyvek lids and a shelf carton
• The configuration can be sterilized by Gamma irradiation, EtO or e-beam
The universal packaging solution is a flexible design that cuts down on
validation costs as well as the validation timeline to release sterile packaged
products to market. The packaging is an efficient design that fits the vast
majority of spinal and extremities implants into a fairly small footprint.
Universal Packaging
Universal Packaging Option (Barger Packaging & Millstone)
Solutions
Outsource
When to Outsource vs. Package In-house
• Limited internal resources
• People
• Capacity
• Equipment
• Tight deadlines
• Aggressive launch dates
• Quality
• Specialized services catered to specific program and customer needs
• Cost Savings
• Experts that can do it better, quicker and for less overall cost
Evaluating a Packaging Partner
Four important considerations when evaluating a packaging partner:
• Quality (Leadership)
• Speed
• Cost
• Expertise
Evaluating a Packaging Partner
Quality:
• Perform a quality audit of the packaging facility
• Evaluate company registrations & certifications
• Class 10,000/ISO7-rated clean rooms
• State of the art equipment and experienced operators
• Evaluate company quality metrics; What are the company’s quality
standards and objectives? DPMO, 6 Sigma, FDA & BSI audit history, etc.
• The best packaging facilities are run by experienced leaders, have skilled
operators and state-of-the-art facilities and equipment.
• Core competency - Expertise
Evaluating a Packaging Partner
Speed:
• Evaluating average lead time for the production of finished goods
(from vendor receipt to final sterilized shipment)
• Utilizing industry “best practices” to be more efficient.
• Increasing through-put and speed to market as well as the ability to
effectively manage vendors are advantages.
Evaluating a Packaging Partner
Cost:
• Quality, speed, and cost are all interrelated.
• Cost of internal clean room is related to expense of labor and
equipment as well as speed to market.
• Reducing labor overhead, developing turn-key processes, validation
services
• Outsourcing packaging requires giving up some control but can be
a cost-effective alternative that, with the right partner, can
enhance quality.
How to Maximize Outsourcing Relationship
• The relationship needs to be a partnership where both companies
mutually benefit
• Understand the company’s core competencies
• Select a partner that can scale with the growth of your company and be able to
support future projects
• Set up open communication between the two companies
• Leverage partner’s experience and knowledge of best practices in the industry
• Benefits include: Speed to market, access to expertise, enhanced quality,
reallocation of internal resources, and reduced costs
Q & A
Kelly Lucenti
klucenti@millstonemedical.com
508.679.8384
Millstone
Millstone Packaging Solutions: Increase speed to market and lower costs

Weitere ähnliche Inhalte

Was ist angesagt?

FDA Update: Inspections, Observations and Metrics - OMTEC 2017
FDA Update: Inspections, Observations and Metrics - OMTEC 2017FDA Update: Inspections, Observations and Metrics - OMTEC 2017
FDA Update: Inspections, Observations and Metrics - OMTEC 2017April Bright
 
CAPA: Using Risk-Based Decision-Making Toward Closure
CAPA: Using Risk-Based Decision-Making Toward ClosureCAPA: Using Risk-Based Decision-Making Toward Closure
CAPA: Using Risk-Based Decision-Making Toward ClosureApril Bright
 
How To Manage and Mitigate Risk in Medical Device New Product Development
How To Manage and Mitigate Risk in Medical Device New Product DevelopmentHow To Manage and Mitigate Risk in Medical Device New Product Development
How To Manage and Mitigate Risk in Medical Device New Product DevelopmentGreenlight Guru
 
UDI: Where Do We Go From Here?
UDI: Where Do We Go From Here?UDI: Where Do We Go From Here?
UDI: Where Do We Go From Here?April Bright
 
Maximizing Use of Your Supplier Scorecard - OMTEC 2018
Maximizing Use of Your Supplier Scorecard - OMTEC 2018Maximizing Use of Your Supplier Scorecard - OMTEC 2018
Maximizing Use of Your Supplier Scorecard - OMTEC 2018April Bright
 
Effective medical device validation introduction manual advance
Effective medical device validation introduction   manual advanceEffective medical device validation introduction   manual advance
Effective medical device validation introduction manual advanceguest2d7d1cac
 
Analyze and Optimize Your Supply Chain Operations for Higher Performance - OM...
Analyze and Optimize Your Supply Chain Operations for Higher Performance - OM...Analyze and Optimize Your Supply Chain Operations for Higher Performance - OM...
Analyze and Optimize Your Supply Chain Operations for Higher Performance - OM...April Bright
 
How to Implement ISO 13485 Updates
How to Implement ISO 13485 UpdatesHow to Implement ISO 13485 Updates
How to Implement ISO 13485 UpdatesApril Bright
 
Effective Medical Device Validation Introduction Web 2
Effective Medical Device Validation Introduction   Web 2Effective Medical Device Validation Introduction   Web 2
Effective Medical Device Validation Introduction Web 2paulsorohan
 
Design and development of medical device
Design and development of medical deviceDesign and development of medical device
Design and development of medical deviceMalesh M
 
21st Century Regulatory Step by Step Compliance Part-1
21st Century Regulatory Step by Step Compliance Part-121st Century Regulatory Step by Step Compliance Part-1
21st Century Regulatory Step by Step Compliance Part-1Md. Saddam Nawaz
 
Life Sciences Product Development
Life Sciences Product DevelopmentLife Sciences Product Development
Life Sciences Product Developmentwraylk
 
Deviations management in the context of ICH Q9 Q10
Deviations management in the context of ICH Q9 Q10Deviations management in the context of ICH Q9 Q10
Deviations management in the context of ICH Q9 Q10Alicia Tébar
 
The Business Case for Integrated Design Controls
The Business Case for Integrated Design ControlsThe Business Case for Integrated Design Controls
The Business Case for Integrated Design ControlsGreenlight Guru
 
medical devices and invitro diagnosis by rahul sagar, m. pharm(dra), bbau luc...
medical devices and invitro diagnosis by rahul sagar, m. pharm(dra), bbau luc...medical devices and invitro diagnosis by rahul sagar, m. pharm(dra), bbau luc...
medical devices and invitro diagnosis by rahul sagar, m. pharm(dra), bbau luc...Brajesh Kumar
 
21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...
21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...
21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...Md. Saddam Nawaz
 

Was ist angesagt? (20)

FDA Update: Inspections, Observations and Metrics - OMTEC 2017
FDA Update: Inspections, Observations and Metrics - OMTEC 2017FDA Update: Inspections, Observations and Metrics - OMTEC 2017
FDA Update: Inspections, Observations and Metrics - OMTEC 2017
 
CAPA: Using Risk-Based Decision-Making Toward Closure
CAPA: Using Risk-Based Decision-Making Toward ClosureCAPA: Using Risk-Based Decision-Making Toward Closure
CAPA: Using Risk-Based Decision-Making Toward Closure
 
How To Manage and Mitigate Risk in Medical Device New Product Development
How To Manage and Mitigate Risk in Medical Device New Product DevelopmentHow To Manage and Mitigate Risk in Medical Device New Product Development
How To Manage and Mitigate Risk in Medical Device New Product Development
 
UDI: Where Do We Go From Here?
UDI: Where Do We Go From Here?UDI: Where Do We Go From Here?
UDI: Where Do We Go From Here?
 
Maximizing Use of Your Supplier Scorecard - OMTEC 2018
Maximizing Use of Your Supplier Scorecard - OMTEC 2018Maximizing Use of Your Supplier Scorecard - OMTEC 2018
Maximizing Use of Your Supplier Scorecard - OMTEC 2018
 
Effective medical device validation introduction manual advance
Effective medical device validation introduction   manual advanceEffective medical device validation introduction   manual advance
Effective medical device validation introduction manual advance
 
Pharmaceutical Documentation
Pharmaceutical DocumentationPharmaceutical Documentation
Pharmaceutical Documentation
 
Analyze and Optimize Your Supply Chain Operations for Higher Performance - OM...
Analyze and Optimize Your Supply Chain Operations for Higher Performance - OM...Analyze and Optimize Your Supply Chain Operations for Higher Performance - OM...
Analyze and Optimize Your Supply Chain Operations for Higher Performance - OM...
 
How to Implement ISO 13485 Updates
How to Implement ISO 13485 UpdatesHow to Implement ISO 13485 Updates
How to Implement ISO 13485 Updates
 
Effective Medical Device Validation Introduction Web 2
Effective Medical Device Validation Introduction   Web 2Effective Medical Device Validation Introduction   Web 2
Effective Medical Device Validation Introduction Web 2
 
Design and development of medical device
Design and development of medical deviceDesign and development of medical device
Design and development of medical device
 
WHO Guidance on Technology Transfers
WHO Guidance on Technology TransfersWHO Guidance on Technology Transfers
WHO Guidance on Technology Transfers
 
21st Century Regulatory Step by Step Compliance Part-1
21st Century Regulatory Step by Step Compliance Part-121st Century Regulatory Step by Step Compliance Part-1
21st Century Regulatory Step by Step Compliance Part-1
 
Life Sciences Product Development
Life Sciences Product DevelopmentLife Sciences Product Development
Life Sciences Product Development
 
Deviations management in the context of ICH Q9 Q10
Deviations management in the context of ICH Q9 Q10Deviations management in the context of ICH Q9 Q10
Deviations management in the context of ICH Q9 Q10
 
The Business Case for Integrated Design Controls
The Business Case for Integrated Design ControlsThe Business Case for Integrated Design Controls
The Business Case for Integrated Design Controls
 
medical devices and invitro diagnosis by rahul sagar, m. pharm(dra), bbau luc...
medical devices and invitro diagnosis by rahul sagar, m. pharm(dra), bbau luc...medical devices and invitro diagnosis by rahul sagar, m. pharm(dra), bbau luc...
medical devices and invitro diagnosis by rahul sagar, m. pharm(dra), bbau luc...
 
Quality Metrics
Quality MetricsQuality Metrics
Quality Metrics
 
21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...
21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...
21st Century Regulatory Step by Step CompliancePart-2 Facility, Utility, Equi...
 
Process Validation Guidances FDA and Global
Process Validation Guidances FDA and GlobalProcess Validation Guidances FDA and Global
Process Validation Guidances FDA and Global
 

Andere mochten auch

Coating Trends Rapid Fire
Coating Trends Rapid Fire Coating Trends Rapid Fire
Coating Trends Rapid Fire April Bright
 
Orthopaedic Device Industry Business Models: 2020 and Beyond
Orthopaedic Device Industry Business Models: 2020 and BeyondOrthopaedic Device Industry Business Models: 2020 and Beyond
Orthopaedic Device Industry Business Models: 2020 and BeyondApril Bright
 
Design for Manufacturability Rapid Fire
Design for Manufacturability Rapid Fire Design for Manufacturability Rapid Fire
Design for Manufacturability Rapid Fire April Bright
 
Modernize the Orthopaedic Supply Chain: A Surgeon’s View
Modernize the Orthopaedic Supply Chain: A Surgeon’s ViewModernize the Orthopaedic Supply Chain: A Surgeon’s View
Modernize the Orthopaedic Supply Chain: A Surgeon’s ViewApril Bright
 
How to Make Postmarket Surveillance More Cost Effective
How to Make Postmarket Surveillance More Cost EffectiveHow to Make Postmarket Surveillance More Cost Effective
How to Make Postmarket Surveillance More Cost EffectiveApril Bright
 
Strategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and AustraliaStrategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and AustraliaApril Bright
 
Steps to Compliance with the European Medical Device Regulations
Steps to Compliance with the European Medical Device RegulationsSteps to Compliance with the European Medical Device Regulations
Steps to Compliance with the European Medical Device RegulationsApril Bright
 
Defining Your Leadership Style in a Performance-Based Organization
Defining Your Leadership Style in a Performance-Based OrganizationDefining Your Leadership Style in a Performance-Based Organization
Defining Your Leadership Style in a Performance-Based OrganizationApril Bright
 
FDA Update and Q&A: UDI
FDA Update and Q&A: UDIFDA Update and Q&A: UDI
FDA Update and Q&A: UDIApril Bright
 
Surgeon Perspective on Additive Manufacturing
Surgeon Perspective on Additive Manufacturing Surgeon Perspective on Additive Manufacturing
Surgeon Perspective on Additive Manufacturing April Bright
 
What Is It? Product Development vs. Product Management
What Is It? Product Development vs. Product Management What Is It? Product Development vs. Product Management
What Is It? Product Development vs. Product Management April Bright
 
Orthopaedic Care Shifts to Outpatient and Urgent Care Clinics
Orthopaedic Care Shifts to Outpatient and Urgent Care ClinicsOrthopaedic Care Shifts to Outpatient and Urgent Care Clinics
Orthopaedic Care Shifts to Outpatient and Urgent Care ClinicsApril Bright
 
Machined vs. Molded
Machined vs. Molded Machined vs. Molded
Machined vs. Molded April Bright
 
Raw Materials Risk Management
Raw Materials Risk Management Raw Materials Risk Management
Raw Materials Risk Management April Bright
 
Pdma Product Development Metrics May 2000
Pdma Product Development Metrics May 2000Pdma Product Development Metrics May 2000
Pdma Product Development Metrics May 2000George Reynolds
 
Determining Quality Metrics for New Product Development Operations
Determining Quality Metrics for New Product Development OperationsDetermining Quality Metrics for New Product Development Operations
Determining Quality Metrics for New Product Development OperationsMasheika Allgood
 
Product development kpi
Product development kpiProduct development kpi
Product development kpibichuklejones
 
Internal KPI reporting for Development Teams
Internal KPI reporting for Development TeamsInternal KPI reporting for Development Teams
Internal KPI reporting for Development TeamsEnric Durany
 

Andere mochten auch (19)

Coating Trends Rapid Fire
Coating Trends Rapid Fire Coating Trends Rapid Fire
Coating Trends Rapid Fire
 
Orthopaedic Device Industry Business Models: 2020 and Beyond
Orthopaedic Device Industry Business Models: 2020 and BeyondOrthopaedic Device Industry Business Models: 2020 and Beyond
Orthopaedic Device Industry Business Models: 2020 and Beyond
 
Design for Manufacturability Rapid Fire
Design for Manufacturability Rapid Fire Design for Manufacturability Rapid Fire
Design for Manufacturability Rapid Fire
 
Modernize the Orthopaedic Supply Chain: A Surgeon’s View
Modernize the Orthopaedic Supply Chain: A Surgeon’s ViewModernize the Orthopaedic Supply Chain: A Surgeon’s View
Modernize the Orthopaedic Supply Chain: A Surgeon’s View
 
Custom Implants
Custom ImplantsCustom Implants
Custom Implants
 
How to Make Postmarket Surveillance More Cost Effective
How to Make Postmarket Surveillance More Cost EffectiveHow to Make Postmarket Surveillance More Cost Effective
How to Make Postmarket Surveillance More Cost Effective
 
Strategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and AustraliaStrategies for Device Approval in China, India, South Korea and Australia
Strategies for Device Approval in China, India, South Korea and Australia
 
Steps to Compliance with the European Medical Device Regulations
Steps to Compliance with the European Medical Device RegulationsSteps to Compliance with the European Medical Device Regulations
Steps to Compliance with the European Medical Device Regulations
 
Defining Your Leadership Style in a Performance-Based Organization
Defining Your Leadership Style in a Performance-Based OrganizationDefining Your Leadership Style in a Performance-Based Organization
Defining Your Leadership Style in a Performance-Based Organization
 
FDA Update and Q&A: UDI
FDA Update and Q&A: UDIFDA Update and Q&A: UDI
FDA Update and Q&A: UDI
 
Surgeon Perspective on Additive Manufacturing
Surgeon Perspective on Additive Manufacturing Surgeon Perspective on Additive Manufacturing
Surgeon Perspective on Additive Manufacturing
 
What Is It? Product Development vs. Product Management
What Is It? Product Development vs. Product Management What Is It? Product Development vs. Product Management
What Is It? Product Development vs. Product Management
 
Orthopaedic Care Shifts to Outpatient and Urgent Care Clinics
Orthopaedic Care Shifts to Outpatient and Urgent Care ClinicsOrthopaedic Care Shifts to Outpatient and Urgent Care Clinics
Orthopaedic Care Shifts to Outpatient and Urgent Care Clinics
 
Machined vs. Molded
Machined vs. Molded Machined vs. Molded
Machined vs. Molded
 
Raw Materials Risk Management
Raw Materials Risk Management Raw Materials Risk Management
Raw Materials Risk Management
 
Pdma Product Development Metrics May 2000
Pdma Product Development Metrics May 2000Pdma Product Development Metrics May 2000
Pdma Product Development Metrics May 2000
 
Determining Quality Metrics for New Product Development Operations
Determining Quality Metrics for New Product Development OperationsDetermining Quality Metrics for New Product Development Operations
Determining Quality Metrics for New Product Development Operations
 
Product development kpi
Product development kpiProduct development kpi
Product development kpi
 
Internal KPI reporting for Development Teams
Internal KPI reporting for Development TeamsInternal KPI reporting for Development Teams
Internal KPI reporting for Development Teams
 

Ähnlich wie Millstone Packaging Solutions: Increase speed to market and lower costs

K11619 rishabh jain
K11619 rishabh jainK11619 rishabh jain
K11619 rishabh jainRishabh Jain
 
Final Io Pp Mdptc Pack Expo Nov 3 2010 3
Final  Io Pp Mdptc Pack Expo Nov 3 2010 3Final  Io Pp Mdptc Pack Expo Nov 3 2010 3
Final Io Pp Mdptc Pack Expo Nov 3 2010 3KKGPackaging
 
Conformity assessment
Conformity assessmentConformity assessment
Conformity assessmenthjselamat
 
Technology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical IndustryTechnology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical IndustryPranjalWagh1
 
Process validation
Process validationProcess validation
Process validationArti Thakkar
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validationMineeta Mahra
 
Pharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical
 
introduction to validation
introduction to validation introduction to validation
introduction to validation Sachin G
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validationamol dighe
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validationamol dighe
 
VALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHAVALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHADhiraj Shrestha
 
types of validation
types of validation types of validation
types of validation AbdulNaim14
 
Qas powerpoint presentation (revised)
Qas powerpoint presentation (revised)Qas powerpoint presentation (revised)
Qas powerpoint presentation (revised)Lidia Turner
 
Pharmaceutical validation
Pharmaceutical  validationPharmaceutical  validation
Pharmaceutical validationPavisara
 
equipmentsvalidation.pdf
equipmentsvalidation.pdfequipmentsvalidation.pdf
equipmentsvalidation.pdfpshashank0409
 
Product Quality
Product Quality Product Quality
Product Quality Arpan Garg
 

Ähnlich wie Millstone Packaging Solutions: Increase speed to market and lower costs (20)

K11619 rishabh jain
K11619 rishabh jainK11619 rishabh jain
K11619 rishabh jain
 
Webinar - Packaging 101.pdf
Webinar - Packaging 101.pdfWebinar - Packaging 101.pdf
Webinar - Packaging 101.pdf
 
Pilot Plant Scale Up Techniques.pdf
Pilot Plant Scale Up Techniques.pdfPilot Plant Scale Up Techniques.pdf
Pilot Plant Scale Up Techniques.pdf
 
Final Io Pp Mdptc Pack Expo Nov 3 2010 3
Final  Io Pp Mdptc Pack Expo Nov 3 2010 3Final  Io Pp Mdptc Pack Expo Nov 3 2010 3
Final Io Pp Mdptc Pack Expo Nov 3 2010 3
 
Conformity assessment
Conformity assessmentConformity assessment
Conformity assessment
 
Technology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical IndustryTechnology Transfer and Scale-up in Pharmaceutical Industry
Technology Transfer and Scale-up in Pharmaceutical Industry
 
Process validation
Process validationProcess validation
Process validation
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
Pharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical Qualification & Validation
Pharmaceutical Qualification & Validation
 
introduction to validation
introduction to validation introduction to validation
introduction to validation
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
Pharmaceutical validation
Pharmaceutical validationPharmaceutical validation
Pharmaceutical validation
 
VALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHAVALIDATION BY DHIRAJ SHRESTHA
VALIDATION BY DHIRAJ SHRESTHA
 
types of validation
types of validation types of validation
types of validation
 
Qas powerpoint presentation (revised)
Qas powerpoint presentation (revised)Qas powerpoint presentation (revised)
Qas powerpoint presentation (revised)
 
Pharmaceutical validation
Pharmaceutical  validationPharmaceutical  validation
Pharmaceutical validation
 
FACTORY ACCEPTANCE TEST
FACTORY ACCEPTANCE TEST FACTORY ACCEPTANCE TEST
FACTORY ACCEPTANCE TEST
 
equipmentsvalidation.pdf
equipmentsvalidation.pdfequipmentsvalidation.pdf
equipmentsvalidation.pdf
 
Product Quality
Product QualityProduct Quality
Product Quality
 
Product Quality
Product Quality Product Quality
Product Quality
 

Mehr von April Bright

The Future of Digital Health and Wearables in Orthopedicsrables
The Future of Digital Health and Wearables in OrthopedicsrablesThe Future of Digital Health and Wearables in Orthopedicsrables
The Future of Digital Health and Wearables in OrthopedicsrablesApril Bright
 
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...April Bright
 
Innovation in Orthopedics: Surgeon Perspectives
Innovation in Orthopedics:  Surgeon PerspectivesInnovation in Orthopedics:  Surgeon Perspectives
Innovation in Orthopedics: Surgeon PerspectivesApril Bright
 
Antimicrobial Coatings: The Research and Regulatory Perspective
Antimicrobial Coatings: The Research and Regulatory PerspectiveAntimicrobial Coatings: The Research and Regulatory Perspective
Antimicrobial Coatings: The Research and Regulatory PerspectiveApril Bright
 
Leverage These Effective Communication Skills to Get Your Message Across
Leverage These Effective Communication Skills to Get Your Message AcrossLeverage These Effective Communication Skills to Get Your Message Across
Leverage These Effective Communication Skills to Get Your Message AcrossApril Bright
 
Operations: Top Reasons for Long Lead Times and What to Do About Them
Operations: Top Reasons for Long Lead Times and What to Do About ThemOperations: Top Reasons for Long Lead Times and What to Do About Them
Operations: Top Reasons for Long Lead Times and What to Do About ThemApril Bright
 
Computational Modeling & Simulation in Orthopedics: Tools to Comply in an Ev...
Computational Modeling & Simulation in Orthopedics:  Tools to Comply in an Ev...Computational Modeling & Simulation in Orthopedics:  Tools to Comply in an Ev...
Computational Modeling & Simulation in Orthopedics: Tools to Comply in an Ev...April Bright
 
Joint Replacement: The Current and Future Impact of Coatings
Joint Replacement: The Current and Future Impact of CoatingsJoint Replacement: The Current and Future Impact of Coatings
Joint Replacement: The Current and Future Impact of CoatingsApril Bright
 
Engineers: Practical Application of Project Management Principles
Engineers: Practical Application of Project Management PrinciplesEngineers: Practical Application of Project Management Principles
Engineers: Practical Application of Project Management PrinciplesApril Bright
 
Regulatory and Quality Affairs: Answers to FDA and ISO Gray Areas
Regulatory and Quality Affairs: Answers to FDA and ISO Gray AreasRegulatory and Quality Affairs: Answers to FDA and ISO Gray Areas
Regulatory and Quality Affairs: Answers to FDA and ISO Gray AreasApril Bright
 
The Future of Orthobiologics in Trauma Procedures
The Future of Orthobiologics in Trauma ProceduresThe Future of Orthobiologics in Trauma Procedures
The Future of Orthobiologics in Trauma ProceduresApril Bright
 
Spine Implants: Porous Coatings vs. Porous Materials vs. Additive Manufacturing
Spine Implants:  Porous Coatings vs. Porous Materials vs. Additive ManufacturingSpine Implants:  Porous Coatings vs. Porous Materials vs. Additive Manufacturing
Spine Implants: Porous Coatings vs. Porous Materials vs. Additive ManufacturingApril Bright
 
How to Influence People: The Value of Employee Engagement
How to Influence People: The Value of Employee EngagementHow to Influence People: The Value of Employee Engagement
How to Influence People: The Value of Employee EngagementApril Bright
 
Real-World Evidence: The Future of Data Generation and Usage
Real-World Evidence: The Future of Data Generation and UsageReal-World Evidence: The Future of Data Generation and Usage
Real-World Evidence: The Future of Data Generation and UsageApril Bright
 
Orthopedic Coatings: Predictions for 2025
Orthopedic Coatings: Predictions for 2025Orthopedic Coatings: Predictions for 2025
Orthopedic Coatings: Predictions for 2025April Bright
 
Engineers: Apply Automation to Increase Quality, Speed to Market
Engineers: Apply Automation to Increase Quality, Speed to MarketEngineers: Apply Automation to Increase Quality, Speed to Market
Engineers: Apply Automation to Increase Quality, Speed to MarketApril Bright
 
OSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
OSMA: Orthopedic Industry's Top Regulatory Challenges and OpportunitiesOSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
OSMA: Orthopedic Industry's Top Regulatory Challenges and OpportunitiesApril Bright
 
Unique Device Identification: Manufacturer, Hospital and Global Implications
Unique Device Identification: Manufacturer, Hospital and Global ImplicationsUnique Device Identification: Manufacturer, Hospital and Global Implications
Unique Device Identification: Manufacturer, Hospital and Global ImplicationsApril Bright
 
Additive Manufacturing - Mechanical Test Methods - OMTEC 2018
Additive Manufacturing - Mechanical Test Methods - OMTEC 2018Additive Manufacturing - Mechanical Test Methods - OMTEC 2018
Additive Manufacturing - Mechanical Test Methods - OMTEC 2018April Bright
 
EU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
EU MDR Preparation: Seize the Market Opportunity and Avoid the BottleneckEU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
EU MDR Preparation: Seize the Market Opportunity and Avoid the BottleneckApril Bright
 

Mehr von April Bright (20)

The Future of Digital Health and Wearables in Orthopedicsrables
The Future of Digital Health and Wearables in OrthopedicsrablesThe Future of Digital Health and Wearables in Orthopedicsrables
The Future of Digital Health and Wearables in Orthopedicsrables
 
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
The Future of Personalized Implants in Joint Replacement: Additive, Robotics,...
 
Innovation in Orthopedics: Surgeon Perspectives
Innovation in Orthopedics:  Surgeon PerspectivesInnovation in Orthopedics:  Surgeon Perspectives
Innovation in Orthopedics: Surgeon Perspectives
 
Antimicrobial Coatings: The Research and Regulatory Perspective
Antimicrobial Coatings: The Research and Regulatory PerspectiveAntimicrobial Coatings: The Research and Regulatory Perspective
Antimicrobial Coatings: The Research and Regulatory Perspective
 
Leverage These Effective Communication Skills to Get Your Message Across
Leverage These Effective Communication Skills to Get Your Message AcrossLeverage These Effective Communication Skills to Get Your Message Across
Leverage These Effective Communication Skills to Get Your Message Across
 
Operations: Top Reasons for Long Lead Times and What to Do About Them
Operations: Top Reasons for Long Lead Times and What to Do About ThemOperations: Top Reasons for Long Lead Times and What to Do About Them
Operations: Top Reasons for Long Lead Times and What to Do About Them
 
Computational Modeling & Simulation in Orthopedics: Tools to Comply in an Ev...
Computational Modeling & Simulation in Orthopedics:  Tools to Comply in an Ev...Computational Modeling & Simulation in Orthopedics:  Tools to Comply in an Ev...
Computational Modeling & Simulation in Orthopedics: Tools to Comply in an Ev...
 
Joint Replacement: The Current and Future Impact of Coatings
Joint Replacement: The Current and Future Impact of CoatingsJoint Replacement: The Current and Future Impact of Coatings
Joint Replacement: The Current and Future Impact of Coatings
 
Engineers: Practical Application of Project Management Principles
Engineers: Practical Application of Project Management PrinciplesEngineers: Practical Application of Project Management Principles
Engineers: Practical Application of Project Management Principles
 
Regulatory and Quality Affairs: Answers to FDA and ISO Gray Areas
Regulatory and Quality Affairs: Answers to FDA and ISO Gray AreasRegulatory and Quality Affairs: Answers to FDA and ISO Gray Areas
Regulatory and Quality Affairs: Answers to FDA and ISO Gray Areas
 
The Future of Orthobiologics in Trauma Procedures
The Future of Orthobiologics in Trauma ProceduresThe Future of Orthobiologics in Trauma Procedures
The Future of Orthobiologics in Trauma Procedures
 
Spine Implants: Porous Coatings vs. Porous Materials vs. Additive Manufacturing
Spine Implants:  Porous Coatings vs. Porous Materials vs. Additive ManufacturingSpine Implants:  Porous Coatings vs. Porous Materials vs. Additive Manufacturing
Spine Implants: Porous Coatings vs. Porous Materials vs. Additive Manufacturing
 
How to Influence People: The Value of Employee Engagement
How to Influence People: The Value of Employee EngagementHow to Influence People: The Value of Employee Engagement
How to Influence People: The Value of Employee Engagement
 
Real-World Evidence: The Future of Data Generation and Usage
Real-World Evidence: The Future of Data Generation and UsageReal-World Evidence: The Future of Data Generation and Usage
Real-World Evidence: The Future of Data Generation and Usage
 
Orthopedic Coatings: Predictions for 2025
Orthopedic Coatings: Predictions for 2025Orthopedic Coatings: Predictions for 2025
Orthopedic Coatings: Predictions for 2025
 
Engineers: Apply Automation to Increase Quality, Speed to Market
Engineers: Apply Automation to Increase Quality, Speed to MarketEngineers: Apply Automation to Increase Quality, Speed to Market
Engineers: Apply Automation to Increase Quality, Speed to Market
 
OSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
OSMA: Orthopedic Industry's Top Regulatory Challenges and OpportunitiesOSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
OSMA: Orthopedic Industry's Top Regulatory Challenges and Opportunities
 
Unique Device Identification: Manufacturer, Hospital and Global Implications
Unique Device Identification: Manufacturer, Hospital and Global ImplicationsUnique Device Identification: Manufacturer, Hospital and Global Implications
Unique Device Identification: Manufacturer, Hospital and Global Implications
 
Additive Manufacturing - Mechanical Test Methods - OMTEC 2018
Additive Manufacturing - Mechanical Test Methods - OMTEC 2018Additive Manufacturing - Mechanical Test Methods - OMTEC 2018
Additive Manufacturing - Mechanical Test Methods - OMTEC 2018
 
EU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
EU MDR Preparation: Seize the Market Opportunity and Avoid the BottleneckEU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
EU MDR Preparation: Seize the Market Opportunity and Avoid the Bottleneck
 

Kürzlich hochgeladen

Scootsy Overview Deck - Pan City Delivery
Scootsy Overview Deck - Pan City DeliveryScootsy Overview Deck - Pan City Delivery
Scootsy Overview Deck - Pan City Deliveryrishi338139
 
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptxerickamwana1
 
Engaging Eid Ul Fitr Presentation for Kindergartners.pptx
Engaging Eid Ul Fitr Presentation for Kindergartners.pptxEngaging Eid Ul Fitr Presentation for Kindergartners.pptx
Engaging Eid Ul Fitr Presentation for Kindergartners.pptxAsifArshad8
 
cse-csp batch4 review-1.1.pptx cyber security
cse-csp batch4 review-1.1.pptx cyber securitycse-csp batch4 review-1.1.pptx cyber security
cse-csp batch4 review-1.1.pptx cyber securitysandeepnani2260
 
Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...
Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...
Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...soumyapottola
 
Testing with Fewer Resources: Toward Adaptive Approaches for Cost-effective ...
Testing with Fewer Resources:  Toward Adaptive Approaches for Cost-effective ...Testing with Fewer Resources:  Toward Adaptive Approaches for Cost-effective ...
Testing with Fewer Resources: Toward Adaptive Approaches for Cost-effective ...Sebastiano Panichella
 
General Elections Final Press Noteas per M
General Elections Final Press Noteas per MGeneral Elections Final Press Noteas per M
General Elections Final Press Noteas per MVidyaAdsule1
 
GESCO SE Press and Analyst Conference on Financial Results 2024
GESCO SE Press and Analyst Conference on Financial Results 2024GESCO SE Press and Analyst Conference on Financial Results 2024
GESCO SE Press and Analyst Conference on Financial Results 2024GESCO SE
 
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunity
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunityDon't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunity
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunityApp Ethena
 
INDIAN GCP GUIDELINE. for Regulatory affair 1st sem CRR
INDIAN GCP GUIDELINE. for Regulatory  affair 1st sem CRRINDIAN GCP GUIDELINE. for Regulatory  affair 1st sem CRR
INDIAN GCP GUIDELINE. for Regulatory affair 1st sem CRRsarwankumar4524
 
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...Sebastiano Panichella
 
Application of GIS in Landslide Disaster Response.pptx
Application of GIS in Landslide Disaster Response.pptxApplication of GIS in Landslide Disaster Response.pptx
Application of GIS in Landslide Disaster Response.pptxRoquia Salam
 
RACHEL-ANN M. TENIBRO PRODUCT RESEARCH PRESENTATION
RACHEL-ANN M. TENIBRO PRODUCT RESEARCH PRESENTATIONRACHEL-ANN M. TENIBRO PRODUCT RESEARCH PRESENTATION
RACHEL-ANN M. TENIBRO PRODUCT RESEARCH PRESENTATIONRachelAnnTenibroAmaz
 
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08LloydHelferty
 

Kürzlich hochgeladen (14)

Scootsy Overview Deck - Pan City Delivery
Scootsy Overview Deck - Pan City DeliveryScootsy Overview Deck - Pan City Delivery
Scootsy Overview Deck - Pan City Delivery
 
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx
05.02 MMC - Assignment 4 - Image Attribution Lovepreet.pptx
 
Engaging Eid Ul Fitr Presentation for Kindergartners.pptx
Engaging Eid Ul Fitr Presentation for Kindergartners.pptxEngaging Eid Ul Fitr Presentation for Kindergartners.pptx
Engaging Eid Ul Fitr Presentation for Kindergartners.pptx
 
cse-csp batch4 review-1.1.pptx cyber security
cse-csp batch4 review-1.1.pptx cyber securitycse-csp batch4 review-1.1.pptx cyber security
cse-csp batch4 review-1.1.pptx cyber security
 
Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...
Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...
Understanding Post Production changes (PPC) in Clinical Data Management (CDM)...
 
Testing with Fewer Resources: Toward Adaptive Approaches for Cost-effective ...
Testing with Fewer Resources:  Toward Adaptive Approaches for Cost-effective ...Testing with Fewer Resources:  Toward Adaptive Approaches for Cost-effective ...
Testing with Fewer Resources: Toward Adaptive Approaches for Cost-effective ...
 
General Elections Final Press Noteas per M
General Elections Final Press Noteas per MGeneral Elections Final Press Noteas per M
General Elections Final Press Noteas per M
 
GESCO SE Press and Analyst Conference on Financial Results 2024
GESCO SE Press and Analyst Conference on Financial Results 2024GESCO SE Press and Analyst Conference on Financial Results 2024
GESCO SE Press and Analyst Conference on Financial Results 2024
 
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunity
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunityDon't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunity
Don't Miss Out: Strategies for Making the Most of the Ethena DigitalOpportunity
 
INDIAN GCP GUIDELINE. for Regulatory affair 1st sem CRR
INDIAN GCP GUIDELINE. for Regulatory  affair 1st sem CRRINDIAN GCP GUIDELINE. for Regulatory  affair 1st sem CRR
INDIAN GCP GUIDELINE. for Regulatory affair 1st sem CRR
 
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...
Testing and Development Challenges for Complex Cyber-Physical Systems: Insigh...
 
Application of GIS in Landslide Disaster Response.pptx
Application of GIS in Landslide Disaster Response.pptxApplication of GIS in Landslide Disaster Response.pptx
Application of GIS in Landslide Disaster Response.pptx
 
RACHEL-ANN M. TENIBRO PRODUCT RESEARCH PRESENTATION
RACHEL-ANN M. TENIBRO PRODUCT RESEARCH PRESENTATIONRACHEL-ANN M. TENIBRO PRODUCT RESEARCH PRESENTATION
RACHEL-ANN M. TENIBRO PRODUCT RESEARCH PRESENTATION
 
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08
Sunlight Spectacle 2024 Practical Action Launch Event 2024-04-08
 

Millstone Packaging Solutions: Increase speed to market and lower costs

  • 1.
  • 2. Millstone Packaging Solutions: Increase speed to market and lower costs Kelly Lucenti, President
  • 3. Common Problems Getting your product to market faster
  • 4. Common Problems • Packaging Development • Understanding different packaging configurations and the benefits, costs and lead times associated with each • Selecting an appropriate sterile barrier • Validating the Design • Validations • Determining necessary validations • Understanding the timeline associated with each validation type • Costs associated with each validation type • Re-executing if a validation fails; time and costs associated re-execution
  • 5. Common Problems • Inadequate resources • Capabilities • Inspection requirements – people and equipment • Cleaning requirements / equipment • Assembly & packaging requirements / equipment • People - not enough operators to support volume and lead time requirements • Equipment • Need more pouch or tray sealers • Need more inspection equipment • Technology is important for running efficient inspection cells & clean room spaces • Capacity • Not enough capacity to support the launch of new product lines • Not enough space for anticipated volumes
  • 6. Common Problems • Staying on top of industry standards • Quality • Mixed product • Inadequate seals • Lead Times • Launch deadlines • Validation lead times
  • 7. Solutions Prepare for successful & timely validations
  • 8. Preparing for successful & timely validations Choose the right packaging configuration • Understand how your device will be used in a clinical setting • Evaluate the benefits of different packaging options Tray Benefits: Compact Design, Space Preferred for Aseptic Transfer Costs: More Lead Times: Molding - 6 weeks Tray Sealing Fixture - 8 weeks Pouch Benefits: Cost Effective, Space Ability to Fit Multiple Designs Costs: Less Lead times: Die - 6 weeks Figure 1
  • 9. • Consider the “problem areas” associated with the device • Sharp edges, weight of implant – anything that could cause a failed validation • Incorporating tip protectors, mounting cards or tray inserts into your package design to protect the implant • What type of sterilization will be required? • Packaging systems must be designed accordingly • For example: EtO requires semi-permeable sterile barriers, allowing gas to enter the packaging without creating a pressure differential that could lead to a burst or leak of the pouch/tray. Being aware of all details can prevent significant delays during the validation process Preparing for successful & timely validations
  • 10. Determine what validations are required Validation Documenting Procedures • Installation Qualification (IQ): Objective Evidence that the manufacturing equipment is installed and connected to the appropriate utilities in accordance with its approved design criteria and the manufacturer’s specifications. • Operational Qualification (OQ): Objective Evidence that the process equipment and ancillary systems, as defined in the Installation Qualification are capable of consistently operating within established limits and tolerances. • Process Qualification (PQ): Objective evidence that the process is effective and reproducible and that the outcome produced meets all requirements for safety and efficacy. ISO requires a methodical, documented process to detail the purpose, scope and procedure of each validation followed by a final report to document the results
  • 11. Validation Types: Sealer IQ Ensure sealer is installed properly Sealing OQ Develop sealing parameters (min, nominal, max) and test at challenge conditions Sealing PQ Test nominal parameters for effective, reproducible results Distribution Testing PQ Test interaction between product & sterile barrier Aging PQ Test the effect of aging on sterile barrier Sealing Validations Determine what validations are required Figure 2
  • 12. Sealing Validations • What is an appropriate sample size? Things to consider: the level of risk severity and probability associated with the given process. If a failure results in significant harm or damage, a larger sample size should be used to validate the process. Bayes Success-Run Theorem – a typical method based on a binomial distribution that leads to a defined sample size. Determine what validations are required Figure 3
  • 13. Sealing Validations • What tests should the samples be subjected to? Things to consider when challenging a sterile barrier: • Qualitative techniques – seal integrity-visual inspection, bubble leak, dye penetration • Quantitative techniques – seal strength Using these test methods, you can develop an acceptance criteria and begin executing. Understanding this beforehand will allow for a seamless transition between package design and validation execution. Determine what validations are required
  • 14. Distribution Testing & Aging Validations Validating the interaction between the product and the sterile barrier These validations must be performed at worst case conditions and should be subjected to qualitative and quantitative test methods. Determine what validations are required Consider Potential Failure Modes DesignTest Figure 4
  • 15. Determine what validations are required Distribution Testing • Validates that the chosen sterile barrier is maintained during the shipping process (according to ASTM D4169). • Involves packaging product into its final packaging configuration (sterile barrier, unit cartons with IFUs, labels, etc.) and subjecting to a defined conditioning and distribution cycle. It is vital to choose a suitable sterile barrier during the design stage to avoid failure during this validation step and prevent significant delays in the validation process. • Company example: Failed ship testing
  • 16. Determine what validations are required Aging Validations / Shelf Life Testing • Validates that the sterile barrier can be maintained through a given period of time which provides an expiration date for the medical device (ASTM F1980). • Accelerated Aging manipulates humidity and temperature levels to hasten the testing process and reach market faster. It is important to note that the ISO standard indicates that Real Time Aging is required to substantiate this data. • To avoid potential issues with Accelerated Aging, be sure to check the pouch/tray supplier’s suggested humidity and temperature levels. Exceeding these can yield negative results due to the extreme conditions. • When testing, it is important to choose the part that has the greatest failure potential to the sterile barrier, thus ensuring that the integrity of the sterile barrier is maintained when the product reaches market.
  • 17. Key Takeaways A failure during these validations can create significant delays in reaching market; failure in the field leads to a recall, liability, and harm to the end-user. Re-execution of validations is costly. Reviewing potential failure modes as well as the intricacies of these validations will provide a proper transition from the process validation stage to getting your product to market in a safe, effective manner. Preparing for successful and timely validations
  • 21. Pre-validated Packaging One of the quickest, easiest, most cost-effective ways to get your medical device to market. • Eliminates tooling & design costs • Packaging available in both tray and pouch configurations • Pre-validated to meet industry recognized standards • Compatible with various methods of sterilization • Reduces resource needs & costs • Increases speed to market (see validation timeline)
  • 23. Universal Packaging One of the quickest, easiest, most cost-effective ways to get more of your products to market • Single packaging configuration that accommodates hundreds to thousands of various sized implants • Reduces validation costs and protocol development • Allows packaging across multiple product lines • Reduces “footprint” of packaging companies
  • 24. Universal Packaging Universal Packaging Option (Barger Packaging & Millstone) • Millstone teamed up with Barger and developed a special packaging that fits roughly 80% of spinal and extremity implants • Double-sterile barrier thermoform tray with two polyurethane liners for protection, inner and outer Tyvek lids and a shelf carton • The configuration can be sterilized by Gamma irradiation, EtO or e-beam The universal packaging solution is a flexible design that cuts down on validation costs as well as the validation timeline to release sterile packaged products to market. The packaging is an efficient design that fits the vast majority of spinal and extremities implants into a fairly small footprint.
  • 25. Universal Packaging Universal Packaging Option (Barger Packaging & Millstone)
  • 27. When to Outsource vs. Package In-house • Limited internal resources • People • Capacity • Equipment • Tight deadlines • Aggressive launch dates • Quality • Specialized services catered to specific program and customer needs • Cost Savings • Experts that can do it better, quicker and for less overall cost
  • 28. Evaluating a Packaging Partner Four important considerations when evaluating a packaging partner: • Quality (Leadership) • Speed • Cost • Expertise
  • 29. Evaluating a Packaging Partner Quality: • Perform a quality audit of the packaging facility • Evaluate company registrations & certifications • Class 10,000/ISO7-rated clean rooms • State of the art equipment and experienced operators • Evaluate company quality metrics; What are the company’s quality standards and objectives? DPMO, 6 Sigma, FDA & BSI audit history, etc. • The best packaging facilities are run by experienced leaders, have skilled operators and state-of-the-art facilities and equipment. • Core competency - Expertise
  • 30. Evaluating a Packaging Partner Speed: • Evaluating average lead time for the production of finished goods (from vendor receipt to final sterilized shipment) • Utilizing industry “best practices” to be more efficient. • Increasing through-put and speed to market as well as the ability to effectively manage vendors are advantages.
  • 31. Evaluating a Packaging Partner Cost: • Quality, speed, and cost are all interrelated. • Cost of internal clean room is related to expense of labor and equipment as well as speed to market. • Reducing labor overhead, developing turn-key processes, validation services • Outsourcing packaging requires giving up some control but can be a cost-effective alternative that, with the right partner, can enhance quality.
  • 32. How to Maximize Outsourcing Relationship • The relationship needs to be a partnership where both companies mutually benefit • Understand the company’s core competencies • Select a partner that can scale with the growth of your company and be able to support future projects • Set up open communication between the two companies • Leverage partner’s experience and knowledge of best practices in the industry • Benefits include: Speed to market, access to expertise, enhanced quality, reallocation of internal resources, and reduced costs
  • 33. Q & A